Olian Judy D. 4

What Happened

• Judy D. Olian, a director of United Therapeutics (UTHR), sold 200 shares of common stock on February 27, 2026. The shares were sold at $509.55 per share for a total transaction value of $101,910. This was a sale (often routine) rather than a purchase.

Key Details

• Transaction date and price: 2026-02-27 — 200 shares at $509.55 each.
• Total proceeds: $101,910.
• Transaction type/code: Sale (open market or private sale; reported as "S").
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The sale was made pursuant to a pre-arranged 10b5-1 trading plan established by Ms. Olian on November 24, 2025 (pre-planned automatic sale).
• Filing date/timeliness: Form filed 2026-03-02; this is within the typical 2-business-day reporting window for a 2026-02-27 transaction.

Context

• 10b5-1 plans allow insiders to sell shares according to a pre-set schedule and are commonly used to avoid trading on material nonpublic information; such sales are often routine and not necessarily a signal of changed sentiment.
• As this is a director sale (not a purchase), it is informational but generally less bullish for investors than insider buys.